Since the founding of CURE by Dr. Morton I. Grosssman in 1973, a strong tradition of expertise has existed for exploring the physiological mechanisms involved in the regulation of GI function under normal and pathological conditions, as recently reviewed by the Animal Models Core Co-Director (1). In the past two decades, tremendous increases in knowledge derived from cell and molecular biological approaches have driven interest to evaluate in vitro findings within the context of integrative physiological models. Conversely, observations derived from the role of specific endogenous hormones or transmitters in the regulation of normal or abnormal GI functions in in vivo models have provided the impetus for focused mechanistic evaluation at the cellular level using molecular biological methods. Indeed, a common theme in many of the research programs of the Center investigators is the elucidation of the pathophysiological role and molecular mechanism of action of gastrointestinal peptide hormones, neuropeptides, paracrine regulators and classical neurotransmitters. Thus, in vivo studies are important for the implementation of many research programs of CURE: DDRCC members to: 1. Assess the biological significance of mechanisms elucidated in vitro; 2. Dissect the neural, hormonal and paracrine mechanisms involved in integrated physiological regulation of GI function; 3. Test biological activity of new reagents (i.e., antibodies, selective receptor agonists or antagonists or novel peptides); 4. Establish relevant models of GI diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK041301-25
Application #
8578090
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
25
Fiscal Year
2014
Total Cost
$95,565
Indirect Cost
$21,121
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Koon, Hon Wai; Wang, Jiani; Mussatto, Caroline C et al. (2018) Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-?B Activity. Antimicrob Agents Chemother 62:
Wang, Jiani; Ghali, Sally; Xu, Chunlan et al. (2018) Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites. Gastroenterology 154:1737-1750
Manatsathit, Wuttiporn; Khrucharoen, Usah; Jensen, Dennis M et al. (2018) Laparotomy and intraoperative enteroscopy for obscure gastrointestinal bleeding before and after the era of video capsule endoscopy and deep enteroscopy: A tertiary center experience. Am J Surg 215:603-609
Rankin, Carl Robert; Theodorou, Evangelos; Man Law, Ivy Ka et al. (2018) Identification of novel mRNAs and lncRNAs associated with mouse experimental colitis and human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 315:G722-G733
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Dong, Tien; Pisegna, Joseph (2018) Passing the ""Acid Test"": Do Proton Pump Inhibitors Affect the Composition of the Microbiome? Dig Dis Sci :
Basheer, Wassim A; Fu, Ying; Shimura, Daisuke et al. (2018) Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia/reperfusion injury. JCI Insight 3:
Jacobs, Jonathan P; Dong, Tien S; Agopian, Vatche et al. (2018) Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatol Res :
Sala-Rabanal, Monica; Ghezzi, Chiara; Hirayama, Bruce A et al. (2018) Intestinal absorption of glucose in mice as determined by positron emission tomography. J Physiol 596:2473-2489
Lin, De-Chen; Dinh, Huy Q; Xie, Jian-Jun et al. (2018) Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas. Gut 67:1769-1779

Showing the most recent 10 out of 1097 publications